Immunology Graduate Group
Recognizing the need to create an environment where researchers could be adequately trained in the multifaceted aspects of immunobiology, Penn became the first medical school to establish a separate degree-granting PhD program in Immunology. The faculty of the Immunology Graduate Group (IGG) are drawn from eight different units of the University of Pennsylvania, encompassing a broad spectrum of research interests: the College of Arts and Sciences; the School of Medicine; the Hospital of the University of Pennsylvania; The Children's Hospital of Philadelphia; the School of Dental Medicine; the School of Veterinary Medicine; The Wistar Institute; and The Abramson Family Cancer Research Institute.
The IGG has also established a partnership with the National Institutes of Health in Bethesda, MD. The partnership brings to the IGG the extraordinary resources and scientific expertise present at the NIH, one of the largest and most renowned biomedical research centers in the world. Students have the opportunity to interact with NIH faculty in a variety of ways, including conducting a lab rotation or thesis work at the NIH. This cross-departmental and institutional organization fosters a unique collaborative environment that allows students to develop research projects combining the expertise of multiple faculty members.
At present, there are approximately 80 faculty members in Penn’s Immunology Graduate Group, encompassing a broad spectrum of research studies. Faculty research includes studies on the development and regulation of the immune system, host-pathogen interactions, the fundamental molecular and cellular biology of the immune system, structural studies of immunologically relevant molecules and translational immunology. Research results are being utilized in both experimental models and clinical trials attempting to fight diseases.
|view IGG's latest e-newsletter|
Gretchan Harms Pritchard on the Role of T-bet in Coordinating T Cell Reponses to Toxplasma Gondii
IGG student Gretchan Harms Pritchard shared her work on the roles for the transcription factorT-bet in effector responses in the January 2nd edition of The Journal of Immunology...More
Henry Daniell Work With Bioengineered Lettuce Featured in Scientific American
Scienctific American featured Dr. Henry Daniell's work in a December 16 article about new research into blood clotting factors to address the problem of immune rejection...More
Yvonne Paterson Explains Research on Listeria and Immunotherapy
In a video for Fox Health, Dr. Yvonne Paterson explains her work using listeria in cancer immunotherapy...More
The Latest Results for CAR Therapy Announced
Drs. Carl June and Stephan Grupp presented the latest results from their clinical trials of the personalized cellular therapy known as CTL019 at the 56th American Society of Hematology Annual Meeting and Exposition...More